Loading...
OTCM
XCRP
Market cap0USD
Mar 04, Last price  
0.00USD
Name

Xcorporeal Inc

Chart & performance

D1W1MN
OTCM:XCRP chart
P/E
0.00
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0
5,326,1921,613,3264,400,000460,98500000000
Net income
-23m
L+34.63%
-7,515,607-3,522,710-6,700,000-8,125,258-1,091,796-7,060,4901,210,517-4,227,435-671,9725,325,016-17,074,051-22,987,273
CFO
-13m
L+18.28%
-6,706,035-2,661,326-5,200,000-1,249,982-112,714-618,466-225,000-225,832-42,771-46,288-10,767,402-12,736,133

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

As of February 4, 2010, Xcorporeal, Inc. commenced the process of winding down and dissolving, a decision made by its board of directors. To facilitate this, the company established the "Xcorporeal, Inc. Liquidating Trust," to which it transferred all corporate assets to manage the final stages of its liquidation. Previously, the firm operated as a medical device company, focusing on developing an extra-corporeal platform technology intended for devices designed to replace the function of various human organs. The company was founded in 2001 and headquartered in Lake Forest, California.

Key people

Lester Sideropoulos
General Partner
Victor Gura
Chief Medical and Scientific Officer · since 2008
Chief Financial Officer, Secretary · since 2007
Kelly McCrann
Chairman of the Board, Chief Executive Officer · since 2008
Director · since 2008
Hans-Dietrich Polaschegg
Director · since 2007
Jay Wolf
Director · since 2006
URL
IPO date
Feb 29, 2000
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show